Document Detail


The role of adrenergic activity in slow coronary flow and its relationship to TIMI frame count.
MedLine Citation:
PMID:  17652227     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this study was to investigate the role of adrenergic activity in patients with slow coronary flow (SCF) and its relationship to TIMI frame count on the pathogenesis of SCF. Plasma noradrenalin and adrenalin concentrations at rest were compared in 51 patients diagnosed with SCF through coronary angiography and TIMI frame count; and 44 healthy controls with normal coronary flow (NCF). Furthermore, the relationship between TIMI frame count and noradrenalin and adrenalin levels was investigated. Plasma noradrenalin (127.9 +/-9.2 and 79.3 +/- 7.3 ng/mL, p < 0.0001) and adrenalin levels (63.9 +/- 2.6 and 44.7 +/- 2.8 ng/mL, p < 0.0001) were higher in patients with SCF when compared to patients with NCF. Noradrenalin and adrenalin levels were effected with SCF-dominant vessels with respect to TIMI frame count (p = 0.012 and p < 0.0001). Patients with SCF in 1, 2, or 3 vessels had different noradrenalin and adrenalin levels (p <0.003 and p < 0.0001). Patients with TIMI frame count above the 75th percentile had significantly higher noradrenalin and adrenalin levels when compared with those between the 25th-50th percentiles and below (p < 0.001 and p = 0.011, respectively). Correlation analysis established that both adrenalin and noradrenalin levels were correlated with TIMI frame counts of left anterior descending (LAD) and circumflex (Cx) arteries. Exercise testing revealed ischemia in 6 patients. Their TIMI frame counts were above the 75th percentile, and they had higher noradrenalin and adrenalin levels when compared with those without ischemia (p = 0.029, p = 0.045). Higher noradrenalin and adrenalin levels and correlation between TIMI frame count and ischemia in patients with SCF suggest that increased adrenergic activity may be the manifestation of slow coronary flow.
Authors:
Mustafa Yazici; Sabri Demircan; Kenan Durna; Mahmut Sahin
Related Documents :
8138937 - Different metabolism of norepinephrine and epinephrine by catechol-o-methyltransferase ...
6150737 - Evidence for a peripheral component in the sympatholytic effect of clonidine in rats.
12054287 - A comparison of catecholamine and cortisol responses of young lambs and calves to painf...
7295467 - Effect of propranolol on noradrenaline kinetics in patients with essential hypertension.
12507057 - A case of levetiracetam (keppra) poisoning with clinical and toxicokinetic data.
3586607 - Pharmacokinetics of penicillin-g in serum and nasal washings of pasteurella multocida f...
Publication Detail:
Type:  Journal Article     Date:  2007-07-24
Journal Detail:
Title:  Angiology     Volume:  58     ISSN:  0003-3197     ISO Abbreviation:  Angiology     Publication Date:    2007 Aug-Sep
Date Detail:
Created Date:  2007-09-18     Completed Date:  2007-10-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0203706     Medline TA:  Angiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  393-400     Citation Subset:  IM    
Affiliation:
Ondokuz Mayis University, Medical School, Department of Cardiology, Samsun, Turkey. drmeyaz@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angina Pectoris / blood*,  physiopathology,  radiography
Biological Markers / blood
Coronary Angiography
Coronary Circulation / physiology*
Disease Progression
Enzyme-Linked Immunosorbent Assay
Epinephrine / blood*
Female
Follow-Up Studies
Humans
Male
Middle Aged
Norepinephrine / blood*
Prognosis
Retrospective Studies
Severity of Illness Index
Vasoconstriction / physiology
Chemical
Reg. No./Substance:
0/Biological Markers; 51-41-2/Norepinephrine; 51-43-4/Epinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessment of arterial distensibility in patients with cardiac syndrome X.
Next Document:  Venous ulcers of the lower limbs due to congenital thalidomide-related valve defect.